Literature DB >> 11169525

Abnormal vitamin B6 metabolism in alkaline phosphatase knock-out mice causes multiple abnormalities, but not the impaired bone mineralization.

S Narisawa1, C Wennberg, J L Millán.   

Abstract

The tissue non-specific alkaline phosphatase (TNAP) knock-out mouse is a model of infantile hypophosphatasia displaying impaired bone mineralization, epileptic seizures, apnoea, abnormal apoptosis in the thymus, abnormal lumbar nerve roots, and postnatal death. Administration of vitamin B6 suppresses the epileptic seizures in TNAP-/- mice. This paper examines to what extent the diverse abnormalities seen in these mice are due to impaired utilization of vitamin B6, using two complementary approaches: administration of vitamin B6 to TNAP null mice and deprivation of vitamin B6 in wild-type and TNAP heterozygous mice. Administration of exogenous pyridoxal HCl delayed the onset of epileptic attacks and increased the life span of TNAP-/- mice. The episodes of apnoea ceased and the appearance of lumbar nerve roots improved, but hypomineralization and accumulation of osteoid continued to worsen with age. Control mice fed a vitamin B6-depleted diet developed epileptic seizures indistinguishable from those observed in TNAP-/- mice, abnormal apoptosis in the thymus, and thinning of the nerve roots, but showed no evidence of bone mineralization abnormalities. Depletion of vitamin B6 did not affect the ability of primary cultures of osteoblasts to deposit bone mineral in vitro. While abnormal metabolism of vitamin B6 explains many of the abnormalities in this mouse model of infantile hypophosphatasia, it is not the basis of the abnormal mineralization that characterizes this disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11169525     DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH722>3.0.CO;2-Y

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  48 in total

1.  Impaired calcification around matrix vesicles of growth plate and bone in alkaline phosphatase-deficient mice.

Authors:  H Clarke Anderson; Joseph B Sipe; Lovisa Hessle; Rama Dhanyamraju; Elisa Atti; Nancy P Camacho; José Luis Millán; Rama Dhamyamraju
Journal:  Am J Pathol       Date:  2004-03       Impact factor: 4.307

2.  Plasma alkaline phosphatase is elevated in Alzheimer's disease and inversely correlates with cognitive function.

Authors:  Katherine Ab Kellett; Jonathan Williams; Emma Rlc Vardy; A David Smith; Nigel M Hooper
Journal:  Int J Mol Epidemiol Genet       Date:  2011-02-10

3.  Hypophosphatasia - pathophysiology and treatment.

Authors:  José Luis Millán; Horacio Plotkin
Journal:  Actual osteol       Date:  2012-09-01

Review 4.  Neonatal seizures: controversies and challenges in translating new therapies from the lab to the isolette.

Authors:  Kevin E Chapman; Yogendra H Raol; Amy Brooks-Kayal
Journal:  Eur J Neurosci       Date:  2012-06       Impact factor: 3.386

5.  Dose response of bone-targeted enzyme replacement for murine hypophosphatasia.

Authors:  Manisha C Yadav; Isabelle Lemire; Pierre Leonard; Guy Boileau; Laurent Blond; Martin Beliveau; Esther Cory; Robert L Sah; Michael P Whyte; Philippe Crine; José Luis Millán
Journal:  Bone       Date:  2011-03-31       Impact factor: 4.398

Review 6.  Cellular function and molecular structure of ecto-nucleotidases.

Authors:  Herbert Zimmermann; Matthias Zebisch; Norbert Sträter
Journal:  Purinergic Signal       Date:  2012-05-04       Impact factor: 3.765

7.  Accelerated fat absorption in intestinal alkaline phosphatase knockout mice.

Authors:  Sonoko Narisawa; Lei Huang; Arata Iwasaki; Hideaki Hasegawa; David H Alpers; José Luis Millán
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

8.  Infantile hypophosphatasia secondary to a novel compound heterozygous mutation presenting with pyridoxine-responsive seizures.

Authors:  Dina Belachew; Traci Kazmerski; Ingrid Libman; Amy C Goldstein; Susan T Stevens; Stephanie Deward; Jerry Vockley; Mark A Sperling; Arcangela L Balest
Journal:  JIMD Rep       Date:  2013-03-12

Review 9.  Phylogeny and chemistry of biological mineral transport.

Authors:  Paul H Schlesinger; Demetrios T Braddock; Quitterie C Larrouture; Evan C Ray; Vladimir Riazanski; Deborah J Nelson; Irina L Tourkova; Harry C Blair
Journal:  Bone       Date:  2020-08-26       Impact factor: 4.398

10.  Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization.

Authors:  Lovisa Hessle; Kristen A Johnson; H Clarke Anderson; Sonoko Narisawa; Adnan Sali; James W Goding; Robert Terkeltaub; José Luis Millan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.